GENOME ANNOUNCEMENT
===================

The genus *Enterovirus* in the family *Picornaviridae* comprises related viruses associated with either asymptomatic infection or various clinical syndromes, including respiratory illness, gastroenteritis, meningitis, encephalitis, and paralytic syndromes ([@B1]). Seven enterovirus (EV) species are known to infect humans: human enteroviruses (HEV) A, B, C, and D and human rhinoviruses A, B, and C (see <http://www.picornaviridae.com/enterovirus/enterovirus.htm>). They are classified according to their nucleotidic identity and peptidic similarity rates within the VP1 region ([@B2], [@B3]). Enteroviruses are small, nonenveloped viruses. The RNA genome is an \~7.5-kb single-stranded, positive-sense, polyadenylated molecule, with a single long open reading frame (ORF) flanked by 5′ and 3′ untranslated regions (UTRs) ([@B4]). This report describes the sequence of an EV-A120 isolate belonging to a new enterovirus type characterized from a partial genome sequence and recently reported (GenBank accession no. KF700245 \[also see <http://www.picornaviridae.com/enterovirus/ev-a/ev-a.htm>\]).

In Madagascar, isolate MAD-2741-11 was obtained from the stool sample of a 3-year-old healthy child living in Toliara, a district located on the southwestern part of the island. This isolate induced a cytopathic effect in both human rhabdomyosarcoma (RD) and human larynx epidermoid carcinoma (HEp-2c) cell lines. Partial overlapping sequences of all genomic regions were obtained using degenerate primers as previously described and a genome-walking method ([@B5][@B6][@B8]). The full genome sequence of isolate MAD-2741-11 was reconstructed and aligned with those of other HEV-A strains using ClustalW. Phylogenetic trees corresponding to different genomic regions were constructed using MEGA 5.2 ([@B9]).

The genome organization of isolate MAD-2741-11 is similar to those of the previously reported EV genomes. The full genome is 7,407 bp in length, excluding the polyadenylated tract. The G+C percentage for the whole genome is 47.5%. The 5′ UTR is 748 nucleotides (nt) long, and the 3′ UTR is 83 nt long. A large open reading frame (6,576 nt) encodes a polyprotein precursor of 2,191 amino acids.

The whole VP1 region (885 nt) of isolate MAD-2741-11 was compared with those of other enterovirus isolates and prototype strains available in nucleotidic sequence databanks. Blast comparison and phylogenetic analysis showed that the VP1 sequence of isolate MAD-2741-11 was closely related to the first and only reported VP1 sequence of the EV-A120 isolate 46402 from Tajikistan (GenBank accession no. KF700245). The two VP1 sequences shared 81.0% nt and 94.6% amino acid identities, in agreement with values for isolates belonging to the same enterovirus type ([@B8]). The P2 and P3 genomic sequences of isolate MAD-2741-11 shared, respectively, 82% and 88% nt identities with those of one of the closest enteroviruses of species A, the coxsackievirus A10 isolate CVA10/SD/CHN/09 (GenBank accession no. HQ728262). The whole polyproteins of the two isolates shared 86% amino acid identity, in agreement with values for isolates belonging to identical enterovirus species ([@B3]). These data indicated that isolate MAD-2741-11 can be unambiguously characterized as an EV-A120 isolate. To our knowledge, this work describes the first full genome sequence of this type of human enterovirus.

Nucleotide sequence accession number. {#h1}
-------------------------------------

The genome sequence of the isolate MAD-2741-11 has been deposited in the ENA database as that of an EV-A120 isolate under the accession no. [LK021688](http://www.ebi.ac.uk/ena/data/view/LK021688).
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